Positive Affect as a Source of Resilience for Adults in Chronic Pain
LARKSPUR
Feasibility of a Positive Affect Skills Intervention for Reducing Racial Disparities in Pain Management
3 other identifiers
interventional
95
1 country
1
Brief Summary
Fibromyalgia syndrome (FMS) is a chronic musculoskeletal condition characterized by widespread pain and tenderness, and often accompanied by impaired physical functioning, depressed mood, as well as deficits in positive affect (PA).Standard behavioral therapies typically focus on minimizing negative thoughts and emotions associated with pain and yield only modest treatment effects. Efforts are therefore needed to develop more effective psychological treatments for chronic pain by identifying new targets for intervention. The objectives of this Stage I randomized pilot trial are to evaluate the feasibility, acceptability, and the impact of a previously developed online positive affect (PA) skills intervention -LARKSPUR (Lessons in Affect Regulation to Keep Stress and Pain UndeR control)-in a sample of Hispanic, non-Hispanic other, and non-Hispanic African American patients with fibromyalgia syndrome (FMS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2021
CompletedFirst Posted
Study publicly available on registry
May 3, 2021
CompletedStudy Start
First participant enrolled
July 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2022
CompletedResults Posted
Study results publicly available
May 1, 2023
CompletedMay 1, 2023
April 1, 2023
11 months
April 10, 2021
March 7, 2023
April 7, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Recruitment as Measured by Rates of Enrollment (Aim 1)
Percent enrolled of total eligible participants.
At baseline
Retention as Measured by Change in Enrollment
Percentage enrolled at baseline that completed the post-intervention assessment.
At baseline; at week 11 (post-intervention)
Helpfulness, Satisfaction, and Impact as Assessed by Self-Report Participant Feedback Survey (Aim 1)
The feedback survey collected two Likert-scale questions asking whether the participant recommends the intervention: (1) "Would you recommend LARKSPUR to a friend?" and (2) "Would you recommend LARKSPUR to someone else with chronic pain?". Both questions were measured on an 11-point scale, with 0=Definitely Not to 10=Definitely Yes. Higher scores indicate better outcomes for both questions. The two items were analyzed separately, not combined.
At week 11 (post-intervention)
Length of Intervention Time as Measured by Number of Weeks to Complete Intervention (Aim 1)
Length of Intervention time as measured by number of weeks the participant took to complete the LARKSPUR intervention program.
At week 11 (post-intervention)
Secondary Outcomes (8)
Change in FMS Pain as Measured by PROMIS Pain Intensity - Short Form 3a (Aim 2)
At baseline; at week 11 (post-intervention); at week 16 (1 month post intervention)
Change in FMS Pain as Measured by PROMIS Pain Interference - Short Form 6b (Aim 2)
At baseline; at week 11 (post-intervention); at week 16 (1 month post intervention)
Change in Physical Functioning as Measured by PROMIS Physical Functioning Short Form 10a (Aim 2)
At baseline; at week 11 (post-intervention); at week 16 (1 month post intervention)
Change in Physical Functioning as Measured by PROMIS Fatigue - Short Form 6a (Aim 2)
At baseline; at week 11 (post-intervention); at week 16 (1 month post intervention)
Change in Depressive Symptoms as Measured by the Center for Epidemiologic Studies Depression Scale Revised (CESD-R-10) (Aim 2)
At baseline; at week 11 (post-intervention); at week 16 (1 month post intervention)
- +3 more secondary outcomes
Other Outcomes (2)
Change in Affective Reactivity to Stress as Measured by the Daily Modified Differential Emotions Scale (mDES)
At baseline, at week 11 (post-intervention); at week 16 (1 month post intervention)
Change in Affective Reactivity to Stress as Measured by the Daily Inventory of Stressful Events (DISE)
At baseline, at week 11 (post-intervention); at week 16 (1 month post intervention)
Study Arms (2)
LARKSPUR intervention
EXPERIMENTALLessons in Affect Regulation to Keep Stress and Pain UndeR control
Attention Control Condition
NO INTERVENTIONDaily emotion reporting/no intervention
Interventions
This intervention used in our prior research consists of skills training exercises designed to increase the frequency of positive affect. The 6 week intervention (5 weeks of content plus one week of home practice) consists of five components: (1) Positive events and gratitude; (2) mindfulness; (3) reappraisal; (4) strength and goals; and(5) acts of kindness. Participants will have up to 8 weeks to complete this intervention.
Eligibility Criteria
You may qualify if:
- Access to daily internet
- ≥ 50 years of age
- Able to read and understand English
- Physician diagnosis confirmation of FMS AND/OR Score ≥ 13 on the 6-item, self-report fibromyalgia screening tool
- Report having pain for at least the last three months
You may not qualify if:
- Cognitive impairment
- Current behavioral treatment for pain
- Enrolled in another pain study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Weill Medical College of Cornell Universitylead
- National Institute on Aging (NIA)collaborator
- Cornell Universitycollaborator
- Wake Forest Universitycollaborator
Study Sites (1)
NewYork-Presbyterian - Weill Cornell Medicine
New York, New York, 10065, United States
Related Publications (3)
Ong AD, Moskowitz JT, Wethington E, Addington EL, Sanni M, Goktas S, Sluys E, Swong S, Kim P, Reid MC. Lessons in Affect Regulation to Keep Stress and Pain UndeR control (LARKSPUR): Design of a randomized controlled trial to increase positive affect in middle-aged and older adults with fibromyalgia. Contemp Clin Trials. 2022 Sep;120:106880. doi: 10.1016/j.cct.2022.106880. Epub 2022 Aug 11.
PMID: 35964867BACKGROUNDOng A, Wilcox K, Reid MC, Wethington E, Cintron D, Addington E, Goktas S, Moskowitz J. Targeting Daily Positive Events to Improve Emotional and Functional Well-Being in Adults With Fibromyalgia: Insights From the LARKSPUR Randomized Controlled Trial. J Med Internet Res. 2024 Dec 10;26:e54678. doi: 10.2196/54678.
PMID: 39657168DERIVEDOng AD, Wilcox KT, Moskowitz JT, Wethington E, Addington EL, Sanni MO, Kim P, Reid MC. Feasibility, Acceptability, and Preliminary Efficacy of a Positive Affect Skills Intervention for Adults With Fibromyalgia. Innov Aging. 2023 Jul 13;7(10):igad070. doi: 10.1093/geroni/igad070. eCollection 2023.
PMID: 38094931DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Anthony Ong
- Organization
- Cornell University
Study Officials
- PRINCIPAL INVESTIGATOR
Anthony Ong, PhD
Cornell University
- PRINCIPAL INVESTIGATOR
Cary Reid, MD PhD
Weill Medical College of Cornell University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2021
First Posted
May 3, 2021
Study Start
July 27, 2021
Primary Completion
June 9, 2022
Study Completion
June 9, 2022
Last Updated
May 1, 2023
Results First Posted
May 1, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Beginning 9 months and ending 36 months following article publication.
- Access Criteria
- Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose.
Reduced, de-identified data sets containing data collected from patients, will be made available for secondary use at the National Archive of Computerized Data on Aging (NACDA), a division of ICPSR at the University of Michigan. NACDA is a repository of survey data on aging that has hundreds of social science research data sets available that are drawn from NIA-funded surveys and data collection efforts. NACDA has established protocols for contributors to reliably de-identify survey participants, regardless of whether they have been assembled as part of national random sample surveys or specialized registry data collection efforts. External users may be asked to provide study aims, variables requested, analytic plans, and targeted journals in their data use requests. They will also be asked to not attempt to re-identify participants, either by merging in administrative, census, medical, or other data, or by using a software program that might re-identify participants.